Altered plasma profile of antioxidant proteins as an early correlate of pancreatic β cell dysfunction

Journal of Biological Chemistry

Volumn 291, Issue 18, 2016, Pages 9648-9656

  Kuo, Taiyi ^a   Kim Muller, Ja Young ^a   McGraw, Timothy E ^b   Accili, Domenico ^a  

^a College of Physicians and Surgeons ^*  (United States)

^b WEILL CORNELL MEDICAL COLLEGE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIOXIDANTS; CYTOLOGY; DRUG PRODUCTS; INSULIN; MAMMALS; MASS SPECTROMETRY; METABOLISM; PHYSIOLOGY; PLASMA DIAGNOSTICS; PLASMA STABILITY; PROTEINS;

ABSOLUTE QUANTIFICATION; ANTIOXIDANT PROTEINS; COAGULATION FACTOR; INSULIN RESISTANCE; INSULIN SECRETION; INSULIN SENSITIVITY; PANCREATIC BETA CELLS; TRANSCRIPTOME ANALYSIS;

CELLS;

ALPHA SYNUCLEIN; AMYLASE; BLOOD CLOTTING FACTOR 13A; BLOOD CLOTTING FACTOR 13A1; BLOOD CLOTTING FACTOR 13B; CARBONATE DEHYDRATASE I; CARBONATE DEHYDRATASE II; CATALASE; CHROMOGRANIN B; DJ 1 PROTEIN; FIBRINOGEN; FIBRINOGEN PRECURSOR ALPHA; FIBRINOGEN PRECURSOR BETA; FIBRINOGEN PRECURSOR GAMMA; GLUCOCORTICOID RECEPTOR; GLUTATHIONE PEROXIDASE 1; GLUTATHIONE TRANSFERASE M1; PEROXIREDOXIN 1; PEROXIREDOXIN 6; PREALBUMIN; RETINOL BINDING PROTEIN 4; SUPEROXIDE DISMUTASE; THIOREDOXIN; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR FKHR; TRANSCRIPTION FACTOR FKHRL1; TRANSCRIPTION FACTOR FOXO4; UNCLASSIFIED DRUG; VON WILLEBRAND FACTOR; ANTIOXIDANT; INCRETIN; PLASMA PROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL DIFFERENTIATION; CONTROLLED STUDY; ENZYME BINDING; EX VIVO STUDY; GLUCOSE HOMEOSTASIS; IN VIVO STUDY; INSULIN RELEASE; MOUSE; NONHUMAN; OXIDATION REDUCTION STATE; PANCREAS DISEASE; PANCREAS ISLET BETA CELL DYSFUNCTION; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN CONTENT; PROTEIN DETERMINATION; PROTEIN FUNCTION; ANIMAL; BLOOD; EXPERIMENTAL DIABETES MELLITUS; GENETICS; KNOCKOUT MOUSE; METABOLISM; NON INSULIN DEPENDENT DIABETES MELLITUS; PANCREAS ISLET BETA CELL; PATHOLOGY;

ANIMALS; ANTIOXIDANTS; BLOOD PROTEINS; DIABETES MELLITUS, EXPERIMENTAL; DIABETES MELLITUS, TYPE 2; INCRETINS; INSULIN-SECRETING CELLS; MICE; MICE, KNOCKOUT;

EID: 84984662070     PISSN: 00219258     EISSN: 1083351X     Source Type: Journal    
DOI: 10.1074/jbc.M115.702183     Document Type: Article

References (52)

1. Abraham, T. M., Pencina, K. M., Pencina, M. J., and Fox, C. S. (2015) Trends in diabetes incidence: the Framingham Heart Study. Diabetes Care 38, 482-487
2. Accili, D. (2004) Lilly lecture 2003: the struggle for mastery in insulin action: from triumvirate to republic. Diabetes 53, 1633-1642
3. Weyer, C, Bogardus, C, Mott, D. M., and Pratley, R. E. (1999) The natural history of insulin secretory dysfunction and insulin resistance in the pathogenesis of type 2 diabetes mellitus. J. Clin. Invest. 104, 787-794
4. Levy, J., Atkinson, A. B., Bell, P. M., McCance, D. R., and Hadden, D. R. (1998) β-Cell deterioration determines the onset and rate of progression of secondary dietary failure in type 2 diabetes mellitus: the 10-year follow-up of the Belfast Diet Study. Diabet. Med. 15, 290-296
5. Wajchenberg, B. L. (2007) β-Cell failure in diabetes and preservation by clinical treatment. Endocr. Rev. 28, 187-218
6. U. K. Prospective Diabetes Study Group. (1998) Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet 352, 837-853;
7. Correction (1999) 354, 602
8. Kahn, S. E., Haffner, S. M., Heise, M. A., Herman, W. H, Holman, R. R., Jones, N. P., Kravitz, B. G., Lachin, J. M., O'Neill, M. C., Zinman, B., and Viberti, G. (2006) Glycemic durability of rosiglitazone, metformin, or glyburide monotherapy. N. Engl. J. Med. 355, 2427-2443;
9. Correction (2007) N. Engl. J. Med. 356, 1387-1388
10. Kahn, S. E. (2003) The relative contributions of insulin resistance and β-cell dysfunction to the pathophysiology of Type 2 diabetes. Diabetologia 46, 3-19
11. Kim-Muller, J. Y., Zhao, S., Srivastava, S., Mugabo, Y., Noh, H. L., Kim, Y. R., Madiraju, S. R., Ferrante, A. W., Skolnik, E. Y., Prentki, M., and Accili, D. (2014) Metabolic inflexibility impairs insulin secretion and results in MODY-like diabetes in triple FoxO-deficient mice. CellMetab. 20, 593-602
12. Mukherjee, P., and Mani, S. (2013) Methodologies to decipher the cell secretome. Biochim. Biophys. Acta 1834, 2226-2232
13. Gerich, J. E. (2002) Is reduced first-phase insulin release the earliest detectable abnormality in individuals destined to develop type 2 diabetes? Diabetes 51, Suppl. 1, S117-S121
14. Wicksteed, B., Brissova, M., Yan, W., Opland, D. M., Plank, J. L., Reinert, R. B., Dickson, L. M., Tamarina, N. A., Philipson, L. H., Shostak, A., Bernal-Mizrachi, E., Elghazi, L., Roe, M. W., Labosky, P. A., Myers, M. G., Jr., etal. (2010) Conditional gene targeting in mouse pancreatic β-cells: analysis of ectopic Cre transgene expression in the brain. Diabetes 59, 3090-3098
15. Tsuchiya, K., Westerterp, M., Murphy, A. J., Subramanian, V., Ferrante, A. W., Jr., Tall, A. R., and Accili, D. (2013) Expanded granulocyte/monocyte compartment in myeloid-specific triple FoxO knockout increases oxidative stress and accelerates atherosclerosis in mice. Circ. Res. 112, 992-1003
16. Ross, P. L., Huang, Y. N., Marchese, J. N., Williamson, B., Parker, K., Hattan, S., Khainovski, N., Pillai, S., Dey, S., Daniels, S., Purkayastha, S., Juhasz, P., Martin, S., Bartlet-Jones, M., He, F., Jacobson, A., and Pappin, D. J. (2004) Multiplexed protein quantitation in Saccharomyces cerevisiae using amine-reactive isobaric tagging reagents. Mol. Cell. Proteomics 3, 1154-1169
17. Kido, Y., Burks, D. J., Withers, D., Bruning, J. C, Kahn, C R., White, M. F., and Accili, D. (2000) Tissue-specific insulin resistance in mice with mutations in the insulin receptor, IRS-1, and IRS-2. J. Clin. Invest. 105, 199-205
18. Talchai, S. C, and Accili, D. (2015) Legacy effect of Foxo1 in pancreatic endocrine progenitors on adult β-cell mass and function. Diabetes 64, 2868-2879
19. Kitamura, T., Kitamura, Y. I., Kobayashi, M., Kikuchi, O., Sasaki, T., Depinho, R. A., and Accili, D. (2009) Regulation of pancreatic juxtaductal endocrine cell formation by FoxO1. Mol. Cell. Biol. 29, 4417-4430
20. Talchai, C, Xuan, S., Lin, H. V., Sussel, L., and Accili, D. (2012) Pancreatic β cell dedifferentiation as a mechanism of diabetic β cell failure. Cell 150, 1223-1234
21. Farrah, T., Deutsch, E. W., Omenn, G. S., Campbell, D. S., Sun, Z., Bletz, J. A., Mallick, P., Katz, J. E., Malmström, J., Ossola, R., Watts, J. D., Lin, B., Zhang, H, Moritz, R. L., and Aebersold, R. (2011) A high-confidence human plasma proteome reference set with estimated concentrations in PeptideAtlas. Mol. Cell. Proteomics 10, M110.006353
22. Obermüller, S., Calegari, F., King, A., Lindqvist, A., Lundquist, I., Salehi, A., Francolini, M., Rosa, P., Rorsman, P., Huttner, W. B., and Barg, S. (2010) Defective secretion of islet hormones in chromogranin-B deficient mice. PLoS ONE 5, e8936
23. Stephan, A. H., Barres, B. A., and Stevens, B. (2012) The complement system: an unexpected role in synaptic pruning during development and disease. Annu. Rev. Neurosci. 35, 369-389
24. Lo, J. C, Ljubicic, S., Leibiger, B., Kern, M., Leibiger, I. B., Moede, T., Kelly, M. E., Chatterjee Bhowmick, D., Murano, I., Cohen, P., Banks, A. S., Khandekar, M. J., Dietrich, A., Flier, J. S., Cinti, S., etal. (2014) Adipsin is an adipokine that improves β cell function in diabetes. Cell 158, 41-53
25. Zemany, L., Bhanot, S., Peroni, O. D., Murray, S. F., Moraes-Vieira, P. M., Castoldi, A., Manchem, P., Guo, S., Monia, B. P., and Kahn, B. B. (2015) Transthyretin antisense oligonucleotides lower circulating RBP4 levels and improve insulin sensitivity in obese mice. Diabetes 64, 1603-1614
26. Matsubara, J., Honda, K., Ono, M., Tanaka, Y., Kobayashi, M., Jung, G., Yanagisawa, K., Sakuma, T., Nakamori, S., Sata, N., Nagai, H, Ioka, T., Okusaka, T., Kosuge, T., Tsuchida, A., et al. (2011) Reduced plasma level of CXC chemokine ligand 7 in patients with pancreatic cancer. Cancer Epidemiol. Biomarkers. Prev. 20, 160-171
27. Stojanovic, I., Saksida, T., and Stosic-Grujicic, S. (2012) β Cell function: the role of macrophage migration inhibitory factor. Immunol. Res. 52, 81-88
28. Vujicic, M., Senerovic, L., Nikolic, I., Saksida, T., Stosic-Grujicic, S., and Stojanovic, I. (2014) The critical role of macrophage migration inhibitory factor in insulin activity. Cytokine 69, 39-46
29. Tiedge, M., Lortz, S., Drinkgern, J., and Lenzen, S. (1997) Relation between antioxidant enzyme gene expression and antioxidative defense status of insulin-producing cells. Diabetes 46, 1733-1742
30. Van De Winkel, M., and Pipeleers, D. (1983) Autofluorescence-activated cell sorting of pancreatic islet cells: purification of insulin-containing B-cells according to glucose-induced changes in cellular redox state. Biochem. Biophys. Res. Commun. 114, 835-842
31. Trus, M., Warner, H., and Matschinsky, F. (1980) Effects of glucose on insulin release and on intermediary metabolism of isolated perifused pancreatic islets from fed and fasted rats. Diabetes 29, 1-14
32. Ivarsson, R., Quintens, R., Dejonghe, S., Tsukamoto, K., in't Veld, P., Renström, E., and Schuit, F. C (2005) Redox control of exocytosis: regulatory role of NADPH, thioredoxin, and glutaredoxin. Diabetes 54, 2132-2142
33. Góth, L., Lenkey, A., and Bigler, W. N. (2001) Blood catalase deficiency and diabetes in Hungary. Diabetes care 24, 1839-1840
34. Atalay, M., Laaksonen, D. E., Niskanen, L., Uusitupa, M., Hänninen, O., and Sen, C. K. (1997) Altered antioxidant enzyme defences in insulin-dependent diabetic men with increased resting and exercise-induced oxidative stress. Acta Physiol. Scand 161, 195-201
35. Kikumoto, Y., Sugiyama, H., Inoue, T., Morinaga, H., Takiue, K., Kitagawa, M., Fukuoka, N., Saeki, M., Maeshima, Y., Wang, D. H., Ogino, K., Masuoka, N., and Makino, H. (2010) Sensitization to alloxan-induced diabetes and pancreatic cell apoptosis in acatalasemic mice. Biochim. Biophys. Acta 1802, 240-246
36. Wang, X., Vatamaniuk, M. Z., Roneker, C. A., Pepper, M. P., Hu, L. G., Simmons, R. A., and Lei, X. G. (2011) Knockouts of SOD1 and GPX1 exert different impacts on murine islet function and pancreatic integrity. Antioxid. Redox Signal. 14, 391-401
37. Harmon, J. S., Bogdani, M., Parazzoli, S. D., Mak, S. S., Oseid, E. A., Berghmans, M., Leboeuf, R. C., and Robertson, R. P. (2009) β-Cell-specific overexpression of glutathione peroxidase preserves intranuclear MafA and reverses diabetes in db/db mice. Endocrinology 150, 4855-4862
38. Arntfield, M. E., and van der Kooy, D. (2011) β-Cell evolution: How the pancreas borrowed from the brain: the shared toolbox of genes expressed by neural and pancreatic endocrine cells may reflect their evolutionary relationship. BioEssays 33, 582-587
39. Eberhard, D. (2013) Neuron and β-cell evolution: learning about neurons is learning about β-cells. BioEssays 35, 584
40. Kim, R. H., Smith, P. D., Aleyasin, H., Hayley, S., Mount, M. P., Pownall, S., Wakeham, A., You-Ten, A. J., Kalia, S. K., Horne, P., Westaway, D., Lozano, A. M., Anisman, H., Park, D. S., and Mak, T. W. (2005) Hypersensitivity of DJ-1-deficient mice to 1-methyl-4-phenyl-1, 2, 3, 6-tetrahydropyrindine (MPTP) and oxidative stress. Proc. Natl. Acad. Sci. U. S. A. 102, 5215-5220
41. Farrer, M. J. (2006) Genetics of Parkinson disease: paradigm shifts and future prospects. Nat. Rev. Genet. 7, 306-318
42. Tsuboi, Y., Munemoto, H., Ishikawa, S., Matsumoto, K., Iguchi-Ariga, S. M., and Ariga, H. (2008) DJ-1, a causative gene product of a familial form of Parkinson's disease, is secreted through microdomains. FEBSLett. 582, 2643-2649
43. Bonifati, V., Rizzu, P., van Baren, M. J., Schaap, O., Breedveld, G. J., Krieger, E., Dekker, M. C., Squitieri, F., Ibanez, P., Joosse, M., van Dongen, J. W., Vanacore, N., van Swieten, J. C., Brice, A., Meco, G., et al. (2003) Mutations in the DJ-1 gene associated with autosomal recessive earlyonset parkinsonism. Science 299, 256-259
44. Jain, D., Jain, R., Eberhard, D., Eglinger, J., Bugliani, M., Piemonti, L., Marchetti, P., and Lammert, E. (2012) Age- and diet-dependent requirement of DJ-1 for glucose homeostasis in mice with implications for human type 2 diabetes. J. Mol. Cell Biol. 4, 221-230
45. Hong, Z., Shi, M., Chung, K. A., Quinn, J. F., Peskind, E. R., Galasko, D., Jankovic, J., Zabetian, C. P., Leverenz, J. B., Baird, G., Montine, T. J., Hancock, A. M., Hwang, H, Pan, C., Bradner, J., et al. (2010) DJ-1 and a-synuclein in human cerebrospinal fluid as biomarkers of Parkinson's disease. Brain 133, 713-726
46. Shi, M., Zabetian, C. P., Hancock, A. M., Ginghina, C., Hong, Z., Yearout, D., Chung, K. A., Quinn, J. F., Peskind, E. R., Galasko, D., Jankovic, J., Leverenz, J. B., and Zhang, J. (2010) Significance and confounders of peripheral DJ-1 and α-synuclein in Parkinson's disease. Neurosci. Lett. 480, 78-82
47. Lin, X., Cook, T. J., Zabetian, C. P., Leverenz, J. B., Peskind, E. R., Hu, S. C, Cain, K. C, Pan, C, Edgar, J. S., Goodlett, D. R., Racette, B. A., Checkoway, H, Montine, T. J., Shi, M., and Zhang, J. (2012) DJ-1 isoforms in whole blood as potential biomarkers of Parkinson disease. Sci. Rep. 2, 954
48. Waanders, L. F., Chwalek, K., Monetti, M., Kumar, C, Lammert, E., and Mann, M. (2009) Quantitative proteomic analysis of single pancreatic islets. Proc. Natl. Acad. Sci. U. S. A. 106, 18902-18907
49. Steneberg, P., Bernardo, L., Edfalk, S., Lundberg, L., Backlund, F., Ostenson, C. G., and Edlund, H. (2013) The type 2 diabetes-associated gene Ide is required for insulin secretion and suppression of α-synuclein levels in β-cells. Diabetes 62, 2004-2014
50. Geng, X., Lou, H., Wang, J., Li, L., Swanson, A. L., Sun, M., Beers-Stolz, D., Watkins, S., Perez, R. G., and Drain, P. (2011) α-Synuclein binds the KATP channel at insulin-secretory granules and inhibits insulin secretion. Am. J. Physiol. Endocrinol. Metab. 300, E276-E286
51. Rodriguez-Araujo, G., Nakagami, H, Takami, Y., Katsuya, T., Akasaka, H., Saitoh, S., Shimamoto, K., Morishita, R., Rakugi, H., and Kaneda, Y. (2015) Low a-synuclein levels in the blood are associated with insulin resistance. Sci. Rep. 5, 12081
52. Pomero, F., Di Minno, M. N., Fenoglio, L., Gianni, M., Ageno, W., and Dentali, F. (2015) Is diabetes a hypercoagulable state? A critical appraisal. Acta Diabetol. 52, 1007-1016